2015•Indonesian Journal of CardiologyOpen access

Paroxysmal Supraventricular Tachycardia Following Ondansentron Intravenous Administration: A Case Report

Erick Hoetama

Open full text 1 citations

Abstract

Ondasentron is selective serotonin 5-HT3 receptor antagonist.It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.This drug become more popular because it's superior efficacy and minimal side effect.Although cardiovascular adverse effect caused by ondansentron administration is rare, some cardiovascular events have been reported, from atrial fibrillation to fatal ventricular tachycardia.This case reports paroxysmal supraventricular tachycardia in male 23 years old following administration of 4 mg intravenous ondansentron.

Open-access reader

About this research paper

What this paper is about

Ondasentron is selective serotonin 5-HT3 receptor antagonist.It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.This drug become more popular because it's superior efficacy and minimal side effect.Although cardiovascular adverse effect caused by ondansentron administration is rare, some cardiovascular events have been reported, from atrial fibrillation to fatal ventricular tachycardia.This case reports paroxysmal supraventricular tachycardia in male 23 years old following administration of 4 mg intravenous ondansentron.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ondasentron is selective serotonin 5-HT3 receptor antagonist.It is widely used as the drug of choice for preventing nausea and vomiting associated with chemotheraphy and post-surgery.This drug become more popular because it's superior efficacy and minimal side effect.Although cardiovascular adverse effect caused by ondansentron administration is rare, some cardiovascular events have been reported, from atrial fibrillation to fatal ventricular tachycardia.This case reports paroxysmal supraventricular tachycardia in male 23 years old following administration of 4 mg intravenous ondansentron.

Key concepts: Medicine, Administration (probate law), Supraventricular tachycardia, Paroxysmal supraventricular tachycardia, Cardiology, Tachycardia, Anesthesia, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Paroxysmal Supraventricular Tachycardia Following Ondansentron Intravenous Administration: A Case Report — Research Paper | ScholarLens